Conclusion: These optimized cCPE-based SPECT imaging agents show great promise as claudin-4–targeting vectors for in vivo imaging of claudin-4 overexpression in pancreatic cancer. The gene discussed is CLDN4; the disease is familial pancreatic carcinoma.